Fuchs' Torsional Phaco Study

Status Completed

Clinical Trial Summary

The primary objective is to compare the effect of torsional phacoemulsification and longitudinal phacoemulsification on central and peripheral corneal thickness/volume after cataract surgery in patients with Fuchs' endothelial dystrophy.

Clinical Trial Description

Fuchs' endothelial dystrophy is a progressive, bilateral disease of the corneal endothelium, which eventually leads to corneal decompensation. In the early stage, some patients develop visually significant cataract. During cataract surgery ultrasound (US) power is used to emulsify the lens, which leads to endothelial cell loss and tissue damage. The reduction of US power has become the primary surgical goal in cataract surgery, which is especially important in patients with Fuchs' endothelial dystrophy to limit endothelial cell loss.

In 2006, Alcon Surgical introduced a torsional mode in its phacoemulsification system (Infiniti Vision System). It includes a handpiece that produces rotary oscillations of the phacoemulsification tip and is suggested to reduce the amount of US power required to remove the cataractous nucleus, because it does not produce repulsion and breaks up the cataract by shearing and not by the conventional jackhammer effect. This reduction in US power, could lead to less endothelial cell damage than the conventional (longitudinal) mode, which is reported recently for patients with hard cataract. It is important to investigate patients with Fuchs' endothelial dystrophy, because patients with a compromised endothelial cell layer will benefit the most from less endothelial cell damage. Consequently, this lower level of endothelial damage may postpone the date of keratoplasty. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00781027
Study type	Interventional
Source	Maastricht University Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03248037` - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation	Phase 3
Recruiting	`NCT03275896` - Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy	Early Phase 1
Completed	`NCT02332109` - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy	N/A
Completed	`NCT02470793` - Technique And Results In Endothelial Keratoplasty	N/A
Recruiting	`NCT01206127` - DSAEK- Postoperative Positioning and Transplant Dislocation	N/A
Recruiting	`NCT03407755` - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)	N/A
Completed	`NCT04140422` - Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea	N/A
Recruiting	`NCT06048380` - The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery	Phase 3
Completed	`NCT02793310` - DMEK Versus DSAEK Study	N/A
Completed	`NCT01795001` - The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Completed	`NCT04057053` - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty	Early Phase 1
Terminated	`NCT01361282` - Using the Optovue OCT to Select IOL Power	N/A
Completed	`NCT02542644` - Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT	N/A
Recruiting	`NCT04191629` - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema	Phase 1
Completed	`NCT05399095` - Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty	N/A
Not yet recruiting	`NCT06261346` - Plasma Rich in Growth Factors in Corneal Endothelial Transplantation	N/A
Completed	`NCT04752020` - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty	Early Phase 1
Not yet recruiting	`NCT05716945` - The OPTIMISE Study	Phase 4
Recruiting	`NCT03575130` - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy	Phase 2
Recruiting	`NCT02118922` - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia